{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:27:20Z","timestamp":1779251240549,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84834-x","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:55:18Z","timestamp":1735876518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive analysis of heat shock protein 110, 90, 70, 60 families and tumor immune microenvironment characterization in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Wenjing","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangdan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"9","key":"84834_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00345-018-2286-7","volume":"36","author":"SH Rossi","year":"2018","unstructured":"Rossi, S. H. et al. Epidemiology and screening for renal cancer. World J. Urol. 36 (9), 1341\u20131353. https:\/\/doi.org\/10.1007\/s00345-018-2286-7 (2018).","journal-title":"World J. Urol."},{"issue":"5","key":"84834_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/path.5022","volume":"244","author":"JJ Hsieh","year":"2018","unstructured":"Hsieh, J. J. et al. Genomic classifications of renal cell carcinoma: A critical step towards the future application of personalized kidney cancer care with pan-omics precision. J. Pathol. 244 (5), 525\u2013537. https:\/\/doi.org\/10.1002\/path.5022 (2018).","journal-title":"J. Pathol."},{"issue":"3","key":"84834_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.eururo.2018.03.036","volume":"74","author":"CJD Wallis","year":"2018","unstructured":"Wallis, C. J. D. et al. First-line systemic therapy for metastatic renal cell carcinoma: A systematic review and network meta-analysis. Eur. Urol. 74 (3), 309\u2013321. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.036 (2018).","journal-title":"Eur. Urol."},{"issue":"9669","key":"84834_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/s0140-6736(09)60229-4","volume":"373","author":"BI Rini","year":"2009","unstructured":"Rini, B. I., Campbell, S. C. & Escudier, B. Ren. cell. Carcinoma Lancet, 373(9669): 1119\u20131132. DOI: https:\/\/doi.org\/10.1016\/s0140-6736(09)60229-4. (2009).","journal-title":"Ren. cell. Carcinoma Lancet"},{"key":"84834_CR5","doi-asserted-by":"publisher","unstructured":"Signoretti, S. et al. Renal cell carcinoma in the era of Precision Medicine: from Molecular Pathology to tissue-based biomarkers. J. Clin. Oncol. 36 (36). https:\/\/doi.org\/10.1200\/jco.2018.79.2259 (2018). Jco2018792259.","DOI":"10.1200\/jco.2018.79.2259"},{"issue":"3","key":"84834_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pharmthera.2012.08.014","volume":"136","author":"T Liu","year":"2012","unstructured":"Liu, T., Daniels, C. K. & Cao, S. Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. Pharmacol. Ther. 136 (3), 354\u2013374. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.08.014 (2012).","journal-title":"Pharmacol. Ther."},{"key":"84834_CR7","doi-asserted-by":"publisher","unstructured":"Sural, S. et al. HSB-1\/HSF-1 pathway modulates histone H4 in mitochondria to control mtDNA transcription and longevity. Sci. Adv. 6 (43). https:\/\/doi.org\/10.1126\/sciadv.aaz4452 (2020).","DOI":"10.1126\/sciadv.aaz4452"},{"key":"84834_CR8","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2741\/2257","volume":"12","author":"AJ Macario","year":"2007","unstructured":"Macario, A. J. & Conway Macario de, E. Molecular chaperones: Multiple functions, pathologies, and potential applications. Front. Biosci. 12, 2588\u20132600 (2007). https:\/\/doi.org\/10.2741\/2257","journal-title":"Front. Biosci."},{"issue":"1","key":"84834_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga, H. H. et al. Guidelines for the nomenclature of the human heat shock proteins. Cell. Stress Chaperones. 14 (1), 105\u2013111. https:\/\/doi.org\/10.1007\/s12192-008-0068-7 (2009).","journal-title":"Cell. Stress Chaperones"},{"issue":"3","key":"84834_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","volume":"38","author":"J Wu","year":"2017","unstructured":"Wu, J. et al. Heat shock proteins and Cancer. Trends Pharmacol. Sci. 38 (3), 226\u2013256. https:\/\/doi.org\/10.1016\/j.tips.2016.11.009 (2017).","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"84834_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.12965\/jer.1632642.321","volume":"12","author":"H Jee","year":"2016","unstructured":"Jee, H. Size dependent classification of heat shock proteins: A mini-review. J. Exerc. Rehabil. 12 (4), 255\u2013259. https:\/\/doi.org\/10.12965\/jer.1632642.321 (2016).","journal-title":"J. Exerc. Rehabil"},{"issue":"7","key":"84834_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3109\/02656736.2010.490254","volume":"26","author":"SK Calderwood","year":"2010","unstructured":"Calderwood, S. K. Heat shock proteins in breast cancer progression\u2013a suitable case for treatment? Int. J. Hyperth. 26 (7), 681\u2013685. https:\/\/doi.org\/10.3109\/02656736.2010.490254 (2010).","journal-title":"Int. J. Hyperth."},{"issue":"8","key":"84834_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3109\/02656731003776968","volume":"26","author":"DR Ciocca","year":"2010","unstructured":"Ciocca, D. R. et al. Heat shock proteins in prostate cancer: From tumorigenesis to the clinic. Int. J. Hyperth. 26 (8), 737\u2013747. https:\/\/doi.org\/10.3109\/02656731003776968 (2010).","journal-title":"Int. J. Hyperth."},{"issue":"7","key":"84834_CR14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1177\/1933719111432875","volume":"19","author":"M Zhao","year":"2012","unstructured":"Zhao, M. et al. Increased expression of heat shock protein 27 correlates with peritoneal metastasis in epithelial ovarian cancer. Reprod. Sci. 19 (7), 748\u2013753. https:\/\/doi.org\/10.1177\/1933719111432875 (2012).","journal-title":"Reprod. Sci."},{"issue":"3","key":"84834_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tibs.2006.01.006","volume":"31","author":"SK Calderwood","year":"2006","unstructured":"Calderwood, S. K. et al. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem. Sci. 31 (3), 164\u2013172 (2006). https:\/\/doi.org\/10.1016\/j.tibs.2006.01.006","journal-title":"Trends Biochem. Sci."},{"key":"84834_CR16","doi-asserted-by":"publisher","unstructured":"Yun, C. W. et al. Heat shock proteins: Agents of cancer development and therapeutic targets in anti-cancer therapy. Cells 9 (1). https:\/\/doi.org\/10.3390\/cells9010060 (2019).","DOI":"10.3390\/cells9010060"},{"key":"84834_CR17","doi-asserted-by":"publisher","unstructured":"Santos, T. G., Martins, V. R. & Hajj, G. N. M. Unconventional secretion of heat shock proteins in Cancer. Int. J. Mol. Sci. 18 (5). https:\/\/doi.org\/10.3390\/ijms18050946 (2017).","DOI":"10.3390\/ijms18050946"},{"issue":"4","key":"84834_CR18","doi-asserted-by":"publisher","first-page":"C739","DOI":"10.1152\/ajpcell.00364.2003","volume":"286","author":"MF Tsan","year":"2004","unstructured":"Tsan, M. F. & Gao, B. Cytokine function of heat shock proteins. Am. J. Physiol. Cell. Physiol. 286 (4), C739\u2013C744. https:\/\/doi.org\/10.1152\/ajpcell.00364.2003 (2004).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"84834_CR19","doi-asserted-by":"publisher","first-page":"540309","DOI":"10.1155\/2014\/540309","volume":"2014","author":"L He","year":"2014","unstructured":"He, L., Deng, T. & Luo, H. S. Heat shock protein 70 gene polymorphisms and cancer risk: A meta-analysis. Sci. World J. 2014, 540309. (2014). https:\/\/doi.org\/10.1155\/2014\/540309","journal-title":"Sci. World J."},{"key":"84834_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3389\/fphar.2020.01029","volume":"11","author":"T Zou","year":"2020","unstructured":"Zou, T. et al. The Association between Heat-shock protein polymorphisms and prognosis in lung cancer patients treated with platinum-based chemotherapy. Front. Pharmacol. 11, 1029. https:\/\/doi.org\/10.3389\/fphar.2020.01029 (2020).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"84834_CR21","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/s1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P. et al. Nomograms in oncology: More than meets the eye. Lancet Oncol. 16 (4), e173\u2013e180. https:\/\/doi.org\/10.1016\/s1470-2045(14)71116-7 (2015).","journal-title":"Lancet Oncol."},{"key":"84834_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.copbio.2016.02.007","volume":"40","author":"F Spill","year":"2016","unstructured":"Spill, F. et al. Impact of the physical microenvironment on tumor progression and metastasis. Curr. Opin. Biotechnol. 40, 41\u201348. https:\/\/doi.org\/10.1016\/j.copbio.2016.02.007 (2016).","journal-title":"Curr. Opin. Biotechnol."},{"issue":"4","key":"84834_CR23","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/JTO.0b013e3182037b76","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes, R. M. et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: Emphasis on non-small cell lung cancer. J. Thorac. Oncol. 6 (4), 824\u2013833. https:\/\/doi.org\/10.1097\/JTO.0b013e3182037b76 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"84834_CR24","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. https:\/\/doi.org\/10.1038\/ncomms3612 (2013).","journal-title":"Nat. Commun."},{"issue":"2","key":"84834_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"MF Sanmamed","year":"2018","unstructured":"Sanmamed, M. F. & Chen, L. A paradigm shift in cancer immunotherapy: From enhancement to normalization. Cell 175 (2), 313\u2013326. https:\/\/doi.org\/10.1016\/j.cell.2018.09.035 (2018).","journal-title":"Cell"},{"issue":"3","key":"84834_CR26","doi-asserted-by":"publisher","first-page":"e2306535","DOI":"10.1002\/advs.202306535","volume":"11","author":"B Li","year":"2024","unstructured":"Li, B. et al. HSPA8 activates Wnt\/\u03b2-Catenin signaling to facilitate BRAF V600E colorectal cancer progression by CMA-Mediated CAV1 degradation. Adv. Sci. (Weinh). 11 (3), e2306535. https:\/\/doi.org\/10.1002\/advs.202306535 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"84834_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-023-01920-w","volume":"23","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target. Mol. Cancer. 23 (1), 19. https:\/\/doi.org\/10.1186\/s12943-023-01920-w (2024).","journal-title":"Mol. Cancer"},{"issue":"6","key":"84834_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68 (6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"84834_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1379\/csc-99r.1","volume":"10","author":"DR Ciocca","year":"2005","unstructured":"Ciocca, D. R. & Calderwood, S. K. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell. Stress Chaperones. 10 (2), 86\u2013103. https:\/\/doi.org\/10.1379\/csc-99r.1 (2005).","journal-title":"Cell. Stress Chaperones"},{"issue":"10","key":"84834_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrm1492","volume":"5","author":"JC Young","year":"2004","unstructured":"Young, J. C. et al. Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell. Biol. 5 (10), 781\u2013791. https:\/\/doi.org\/10.1038\/nrm1492 (2004).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"84834_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fmolb.2020.00060","volume":"7","author":"A Hoter","year":"2020","unstructured":"Hoter, A. et al. Heat shock protein 60 in hepatocellular carcinoma: Insights and perspectives. Front. Mol. Biosci. 7, 60. https:\/\/doi.org\/10.3389\/fmolb.2020.00060 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"84834_CR32","doi-asserted-by":"publisher","first-page":"100888","DOI":"10.1016\/j.drup.2022.100888","volume":"65","author":"B Parma","year":"2022","unstructured":"Parma, B. et al. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins. Drug Resist. Updat. 65, 100888. https:\/\/doi.org\/10.1016\/j.drup.2022.100888 (2022).","journal-title":"Drug Resist. Updat"},{"key":"84834_CR33","doi-asserted-by":"publisher","first-page":"726244","DOI":"10.3389\/fmolb.2021.726244","volume":"8","author":"LR Yan","year":"2021","unstructured":"Yan, L. R. et al. Comprehensive pan-cancer analysis of Heat shock protein 110, 90, 70, and 60 families. Front. Mol. Biosci. 8, 726244. https:\/\/doi.org\/10.3389\/fmolb.2021.726244 (2021).","journal-title":"Front. Mol. Biosci."},{"issue":"23","key":"84834_CR34","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1080\/15384101.2019.1673633","volume":"18","author":"C Fang","year":"2019","unstructured":"Fang, C. et al. Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the mir-223-HSP90B1 axis. Cell. Cycle. 18 (23), 3288\u20133299. https:\/\/doi.org\/10.1080\/15384101.2019.1673633 (2019).","journal-title":"Cell. Cycle"},{"key":"84834_CR35","doi-asserted-by":"publisher","first-page":"653711","DOI":"10.3389\/fimmu.2021.653711","volume":"12","author":"R Zhao","year":"2021","unstructured":"Zhao, R. et al. The N(6)-Methyladenosine-modified pseudogene HSPA7 correlates with the tumor microenvironment and predicts the response to immune checkpoint therapy in glioblastoma. Front. Immunol. 12, 653711. https:\/\/doi.org\/10.3389\/fimmu.2021.653711 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"84834_CR36","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.3892\/ol.2018.7800","volume":"15","author":"W Chen","year":"2018","unstructured":"Chen, W. et al. HSPA12B overexpression induces cisplatin resistance in non-small-cell lung cancer by regulating the PI3K\/Akt\/NF-\u03baB signaling pathway. Oncol. Lett. 15 (3), 3883\u20133889. https:\/\/doi.org\/10.3892\/ol.2018.7800 (2018).","journal-title":"Oncol. Lett."},{"issue":"34","key":"84834_CR37","doi-asserted-by":"publisher","first-page":"35893","DOI":"10.18632\/oncotarget.5651","volume":"6","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. The potent tumor suppressor miR-497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L. Oncotarget 6 (34), 35893\u201335907. https:\/\/doi.org\/10.18632\/oncotarget.5651 (2015).","journal-title":"Oncotarget"},{"key":"84834_CR38","doi-asserted-by":"publisher","unstructured":"Choi, S. I. et al. HSPA1L enhances Cancer Stem Cell-Like Properties by activating IGF1R\u03b2 and regulating \u03b2-Catenin transcription. Int. J. Mol. Sci. 21 (18). https:\/\/doi.org\/10.3390\/ijms21186957 (2020).","DOI":"10.3390\/ijms21186957"},{"issue":"5","key":"84834_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1084\/jem.194.5.629","volume":"194","author":"K Nakamura","year":"2001","unstructured":"Nakamura, K., Kitani, A. & Strober, W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194 (5), 629\u2013644. https:\/\/doi.org\/10.1084\/jem.194.5.629 (2001).","journal-title":"J. Exp. Med."},{"issue":"12","key":"84834_CR40","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1517\/14712590802494022","volume":"8","author":"PA Bignone","year":"2008","unstructured":"Bignone, P. A. & Banham, A. H. FOXP3\u2009+\u2009regulatory T cells as biomarkers in human malignancies. Expert Opin. Biol. Ther. 8 (12), 1897\u20131920. (2008). https:\/\/doi.org\/10.1517\/14712590802494022","journal-title":"Expert Opin. Biol. Ther."},{"issue":"13","key":"84834_CR41","first-page":"5132","volume":"61","author":"O Nakano","year":"2001","unstructured":"Nakano, O. et al. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res. 61 (13), 5132\u20135136 (2001).","journal-title":"Cancer Res."},{"key":"84834_CR42","doi-asserted-by":"publisher","unstructured":"Serzan, M. T. & Atkins, M. B. Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinoma. J. Cancer Metastasis Treat. 7 https:\/\/doi.org\/10.20517\/2394-4722.2021.76 (2021).","DOI":"10.20517\/2394-4722.2021.76"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84834-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T04:38:20Z","timestamp":1735965500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84834-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84834"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84834-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"469"}}